10-Q/A: FutureFuel Corp. Restates Q3 2023 Financials Due to Cash Flow Errors

Sentiment:

Quarterly Report Amendment


FutureFuel Corp. has filed an amended 10-Q report to correct errors in its statement of cash flows for the third quarter of 2023, also impacting prior periods.

Worse than expectedThe company's Q3 2023 net income was significantly lower than the same period in 2022, indicating worse than expected results.The company identified a material weakness in internal control over financial reporting, which is a negative indicator.

Summary

  • FutureFuel Corp. has restated its financial statements for the third quarter of 2023 due to errors in the statement of cash flows.
  • The errors primarily affected the reported amounts of 'Other assets', 'Net Cash Flows From Operating Activities', 'Collateralization of derivative instruments', and 'Net Cash Flows from Investing Activities'.
  • The restatement does not impact the company's overall cash position, balance sheets, statements of operations, or statements of stockholders' equity.
  • The company has identified a material weakness in its internal control over financial reporting related to the review of cash flows.
  • The company's revenue for the three months ended September 30, 2023, was $116.75 million, a slight decrease from $118.14 million in the same period of 2022.
  • Net income for the three months ended September 30, 2023, was $2.78 million, significantly down from $15.78 million in the same period of 2022.
  • For the nine months ended September 30, 2023, revenue was $276.24 million, slightly down from $278.20 million in the same period of 2022.
  • Net income for the nine months ended September 30, 2023, was $14 million, a significant increase from $0.28 million in the same period of 2022.
  • The company held 4.2 million RINs with a fair market value of $6.97 million as of September 30, 2023, compared to 8.1 million RINs with a fair market value of $12.75 million as of September 30, 2022.

Sentiment

Score: 4

Explanation: The sentiment is negative due to the restatement of financials, the identification of a material weakness in internal controls, and the significant decrease in Q3 net income. However, the company's strong cash position and positive nine-month net income provide some offsetting factors.

Positives

  • The company's nine-month net income significantly increased to $14 million from $0.28 million in the prior year.
  • The company's adjusted EBITDA for the nine months ended September 30, 2023 was $18.23 million, compared to $10.64 million for the same period in 2022.
  • The company has implemented a remediation plan to address the material weakness in internal controls.
  • The company has a strong cash position with $205.92 million in cash and cash equivalents as of September 30, 2023.

Negatives

  • The company restated its Q3 2023 financials due to errors in the statement of cash flows.
  • A material weakness in internal control over financial reporting was identified.
  • Q3 2023 net income decreased significantly to $2.78 million from $15.78 million in Q3 2022.
  • Gross profit for the three months ended September 30, 2023 decreased by $16.115 million compared to the same period in 2022.
  • The biofuel segment experienced a gross loss of $3.01 million in the three months ended September 30, 2023.

Risks

  • The company's internal control over financial reporting was deemed ineffective as of September 30, 2023.
  • The company's financial results are subject to fluctuations in commodity prices, particularly biofuel and feedstock prices.
  • The company's biofuel segment is exposed to the volatility of RIN prices.
  • The company's reliance on a few major customers in the biofuel segment poses a risk if those relationships change.
  • The company's derivative instruments do not qualify for hedge accounting, leading to potential volatility in reported earnings.

Future Outlook

The company believes that existing cash balances, cash flow from operations, and borrowing capacity will be sufficient to fund operations, product development, cash dividends, and capital requirements for the foreseeable future. The company does not anticipate the need to issue securities to fund capital requirements.

Management Comments

  • Management believes that the diversity of each segment strengthens the company in the ability to utilize resources and is committed to growing each segment.
  • Management believes that adjusted EBITDA permits a comparative assessment of our operating performance and liquidity, relative to a performance and liquidity based on GAAP results.
  • Management has determined that none of the net deferred tax assets generated on its 2023 tax losses are more likely than not to be realized.

Industry Context

The company operates in the biofuels and specialty chemicals industries, which are subject to regulatory changes, commodity price fluctuations, and market competition. The decrease in D4 RIN prices due to increased renewable diesel production highlights the competitive pressures in the biofuel market. The company's reliance on a few major customers in the biofuel segment is a common practice in the industry, but it also presents a risk.

Comparison to Industry Standards

  • FutureFuel's restatement of financials due to cash flow errors is not typical for large, established companies and indicates a weakness in internal controls compared to industry best practices.
  • The company's adjusted EBITDA margin of approximately 6.6% for the nine months ended September 30, 2023, is relatively low compared to some specialty chemical companies, but is more typical for biofuel companies.
  • The company's reliance on derivative instruments to manage commodity price risk is a common practice in the industry, but the lack of hedge accounting designation exposes the company to volatility in reported earnings.
  • Compared to companies like Renewable Energy Group (now part of Chevron), FutureFuel's biofuel segment is smaller and more focused on biodiesel, while Renewable Energy Group had a broader portfolio including renewable diesel.
  • Compared to specialty chemical companies like Albemarle or FMC, FutureFuel's chemical segment is smaller and more focused on custom manufacturing, while Albemarle and FMC have a broader range of products and markets.

Related Party Transactions

  • The company engages in transactions with companies affiliated with or controlled by a director and significant shareholder.
  • Related party revenues are from sales of biodiesel, petrodiesel, blends, and other petroleum products.
  • Related party cost of goods sold and distribution are from sales and purchases of biodiesel, petrodiesel, blends, and other petroleum products, along with storage and terminalling services.

Stakeholder Impact

  • Shareholders may be concerned about the restatement and the material weakness in internal controls.
  • Employees may be affected by the changes in internal control procedures.
  • Customers may be impacted by any changes in the company's operations or financial stability.
  • Suppliers may be affected by any changes in the company's purchasing practices.
  • Creditors may be concerned about the company's financial stability and ability to repay debts.

Next Steps

  • The company is implementing additional review procedures to enhance internal control over financial reporting.
  • The company will continue to evaluate its deferred tax assets quarterly.
  • The company will continue to monitor and manage its exposure to commodity price risk.

Key Dates

DateDescription
2020-03-30The company amended and restated its credit agreement.
2023-03-01The company entered into a First Amendment to the Credit Agreement.
2023-09-30End of the quarterly period for the financial statements being restated.
2023-11-09Original Form 10-Q was initially filed with the SEC.
2024-05-08Management and the audit committee determined that certain financial statements contained errors.
2024-05-09The company filed a Current Report on Form 8-K disclosing the restatement.
2024-05-10Date of the amended 10-Q/A filing.

Keywords

restatement, financial statements, cash flow, internal control, material weakness, biofuel, chemicals, RINs, EBITDA, derivative instruments

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.